ABAnnie Britton

Annie Britton

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Annie Britton has a total of 141 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Improving Short‐ and Long‐Term Type 2 Diabetes Risk Prediction for Middle‐Aged British Adults

    by Cunrong Huang, Andre Lopes, Annie Britton

    Aims: Diabetes prediction tools are valuable for prevention and resource planning. Few tools exist to predict long‐term diabetes risk for British adults. We aim to develop and validate a diabetes prediction tool for short‐ and long‐term risk. Materials and Methods: Prediction model development (Training, n = 4502) and internal validation (Test, n = 1929) used Whitehall II data (WHII); external validation used English Longitudinal Study of Ageing (ELSA) data, with incident diabetes as outcome. Predictors were selected using LASSO‐Cox, random survival forests (RSF) and best subset selection. Three candidate Cox models were built from these predictor sets and compared. Performance was assessed with C ‐indices, calibration and decision curve analysis (DCA). A continuous risk score and quartile‐based risk groups were derived; a nomogram was created. Results: Across WHII Test (235 events) and ELSA (255 events), three models showed broadly similar discrimination, calibration and DCA patterns. LASSO‐ and RSF‐selected models performed comparably and slightly better than best subset. LASSO and RSF both selected ethnicity, body mass index, waist‐to‐height ratio, height, triglyceride‐glucose index, fasting glucose, family history of diabetes and socioeconomic status; LASSO additionally selected smoking, whereas RSF also included age, triglycerides, high‐density lipoprotein cholesterol, systolic and diastolic blood pressure. In ELSA, risk‐score C ‐indices (95% CIs) were 0.800 (0.773–0.827) for the LASSO‐selected model and 0.801 (0.774–0.827) for the RSF‐selected model; risk‐group C ‐indices were 0.737 (0.715–0.759) and 0.727 (0.707–0.748), respectively. Conclusions: We developed and externally validated a tool to estimate 5‐, 10‐ and 15‐year diabetes risk in British middle‐aged adults, which may support primary care decision‐making.

  • Open Access

    Circulating metabolomic signatures of ultra-processed and minimally processed food intake and risk of cardiovascular disease and type 2 diabetes: 20-year follow-up in the Whitehall II cohort

    by Mengmei E. Wang, Annie Britton, Michail Katsoulis, Kiara Chang, Eszter P. Vamos, Clare H. Llewellyn

    Background: Higher intakes of ultra-processed food (UPF) and minimally processed food (MPF) are linked to increased and decreased cardiometabolic risks, respectively, though mechanisms underlying these associations remain less understood. We aimed to identify metabolomic signatures associated with UPF and MPF intakes, examine their prospective associations with cardiovascular disease (CVD) and type 2 diabetes (T2D), and quantify their mediation of processing-disease associations. Methods: In the Whitehall II cohort, UPF and MPF intakes in 6010 participants were derived using the Nova classification from 127-item food frequency questionnaires administered at phases 3 and 5 (1991–1994, 1997–1999), averaged across phases. Fasting plasma samples were analysed for 233 metabolites using nuclear magnetic resonance (NMR) spectroscopy. Metabolomic signatures for UPF and MPF intake were derived using elastic net regression. Cox models examined associations between metabolomic signatures and incident CVD and T2D. Mediation analyses quantified the proportion explained by metabolomic signatures. Results: We identified metabolomic signatures for UPF (34 metabolites) and MPF (50 metabolites). The UPF signature correlated positively with pro-inflammatory and atherogenic metabolites and inversely with omega-3 fatty acids and high-density lipoproteins; the MPF signature showed the opposite pattern. 1094 CVD and 853 T2D events occurred over 20 and 18 years median follow-up, respectively. Comparing the highest to lowest tertile, higher UPF signature scores were associated with greater risk of (hazard ratio [HR] = 1.19; 95% confidence interval [CI] 1.02–1.39) and T2D (HR = 1.20; 95% CI 1.03–1.42), whereas higher MPF signature scores were inversely associated with these outcomes (CVD: HR = 0.81; 95% CI 0.69–0.94; T2D: HR = 0.60; 95% CI 0.48–0.73). Associations between the signatures and outcomes were robust to additional adjustment for UPF or MPF intake. The signatures mediated 42.8–51.1% of processing-disease associations (51.1% for UPF-CVD, 46.6% for MPF-CVD, 42.8% for UPF-T2D, and 47.8% for MPF-T2D; all p < 0.05). Conclusions: Metabolomic signatures of UPF and MPF intake showed opposing associations with CVD and T2D risk, partially mediating these processing–disease associations. These findings suggest biological pathways linking UPF intake to adverse cardiometabolic outcomes, though the unexplained proportion indicates additional mechanisms may contribute.


  • Open Access

    Bi-directional associations between alcohol consumption and pain among non-manual workers: a random-intercept cross-lagged panel analysis in the British Whitehall II cohort study

    by Ziyi Zhao, Tea Lallukka, Tarani Chandola, Annie Britton

    Aims: The direction and temporality of the association between alcohol use and pain remain understudied among non-manual workers. This study investigated bidirectional associations between alcohol consumption and pain among current and retired non-manual workers, with exploratory subgroup analyses by retirement transition status, retirement age, and socioeconomic position (SEP). Methods: Survey data from Phases 7, 9, and 12 (2002–15) of the Whitehall II cohort study were analyzed (n = 5928, baseline mean age 60.7 years, 71% men). Alcohol consumption was assessed through self-reported intake converted to pure alcohol units. Pain severity was derived from musculoskeletal pain-site number and RAND-36 bodily pain measures, categorized as none, mild, or moderate/severe. Random-intercept cross-lagged panel models without equality constraints estimated within-person associations, with subgroup analyses by retirement transition and SEP. Results: At baseline, 23.1% reported above-moderate pain severity and 30.0% exceeded recommended limits (>14 units/week). During 14-year follow-up, 47.3% remained retired, 10.1% were employed, and 40.1% transitioned from employment to retirement. Elevated alcohol consumption was associated with increased pain severity among all participants (βP7 → P9 = 0.07, 95% confidence interval [CI]: 0.02–0.12; βP9 → P12 = 0.04, 95% CI: 0.00–0.08), with stronger effect among midlife retirees (βP9→P12 = 0.15, 95% CI: 0.04–0.25) and low-SEP participants (βP9→P12 = 0.22, 95% CI: 0.04–0.51). Pain was associated with alcohol consumption at earlier intervals, but associations attenuated subsequently. Conclusions: Elevated alcohol consumption might be associated with increased pain severity among non-manual workers, particularly midlife retirees and low-SEP individuals. Pain-to-alcohol associations were observed but were inconsistent across intervals.

  • Open Access

    Ten-year trajectories of ultra-processed food intake and prospective associations with cardiovascular diseases and all-cause mortality: findings from the Whitehall II cohort study

    by Mengmei E. Wang, Clare H. Liewellyn, Michail Katsoulis, Tasnime N. Akbaraly, Samuel J. Dicken, Jiahao Liu, Adrian Brown, Annie Britton

    Background: Ultra-processed food (UPF) intake has been associated with adverse health outcomes; however, research on UPF intake and cardiovascular disease (CVD) prognosis has largely neglected its longitudinal pattern over time. This study investigated trajectories of UPF intake over a decade and their prospective associations with the risk of fatal and non-fatal CVD, as well as all-cause mortality, using data spanning from 16 to 19 years. Methods: This study utilized data from the British Whitehall II cohort study, including 7,138 participants (68.3% male; median baseline age 60.4 years), all free of CVD at baseline. Dietary intake was assessed using a validated 127-item food frequency questionnaire at three time points: phase 3 (1991–1994), phase 5 (1997–1999), and phase 7 (2002–2004). UPF intake was estimated using the Nova classification, and group-based trajectory modelling identified different longitudinal consumption patterns. Phase 7 (2002–2004) was the baseline for subsequent monitoring of cardiovascular events and mortality outcomes until 2019/2021. Multivariate Cox proportional hazards models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs), adjusting for socio-demographics, lifestyle, diet quality, energy intake, and clinical factors. Results: Three distinct UPF trajectory groups were identified: high (26.2% of participants), moderate (52.9%) and low UPF intake (20.9%). All groups showed a slight increase in UPF intake over time. Over the median follow-up of 16 years for incident cases and 19 years for mortality, we observed 1,128 incident CVD events, 859 CHD cases and 1,314 deaths. The highest vs. lowest UPF intake group had a 23% higher risk of CVD (HR 1.23, 95% CI 1.01 to 1.40), and a 32% higher risk of CHD (HR 1.32, 95% CI 1.06 to 1.65). No significant associations were observed between UPF trajectory groups and CVD mortality, CHD mortality, or all-cause mortality. Conclusions: Sustained high UPF intake over 10 years was associated with increased risks of non-fatal CVD and CHD but not with CVD-specific, CHD-specific, or all-cause mortality. These findings suggest that sustained high intake of UPF may be a modifiable risk factor for preventing non-fatal cardiovascular risks.


  • Open Access

    Steatotic liver disease is a marker of multimorbidity, not underlying cirrhosis, in older adults

    by O. Oduwole, C. Ding, N. Bitar, D. Nair, S. Salter, M. Silverman, R. Allen, L. Ng Fat, E. Tsochatzis, S. Bell, et al.

    Steatotic liver disease (SLD) prevalence in adults is estimated at 30%, but older populations are understudied. Here, SLD prevalence and associated risk factors were assessed 1,021 Whitehall II study participants (mean age 72.5) using transient elastography (FibroScan). SLD was present in 33.3% (CAP ≥ 275 dB/m), with most classified as metabolic dysfunction-associated SLD. Only 2.4% had significant fibrosis ( ≥ 7.9 kPa). Adjusted for age and sex, SLD was associated with low physical activity (OR 1.60, 95% CI 1.13-2.27), poorer motor function (SF-36 PCS OR 1.21, 95% CI 1.05-1.40), difficulties in activities of daily living (OR 3.19, 95% CI 1.17-8.64), and multimorbidity (OR 1.45, 95% CI 1.22-1.73). These associations persisted after adjustment for socioeconomic, behavioural, and cardiometabolic risk factors. Frailty was associated with SLD at higher CAP thresholds ( ≥ 290 dB/m). In this older adult sample, SLD is common and appears more as a marker of multimorbidity and low physical activity than significant fibrosis.


  • Open Access

    Prognostic Significance and Associations of Neural Network–Derived Electrocardiographic Features

    by Arunashis Sau, Antônio H Ribeiro, Kathryn A McGurk, Libor Pastika, Nikesh Bajaj, Mehak Gurnani, Ewa Sieliwonczyk, Konstantinos Patlatzoglou, Maddalena Ardissino, Jun Yu Chen, et al.

    BACKGROUND: Subtle, prognostically important ECG features may not be apparent to physicians. In the course of supervised machine learning, thousands of ECG features are identified. These are not limited to conventional ECG parameters and morphology. We aimed to investigate whether neural network–derived ECG features could be used to predict future cardiovascular disease and mortality and have phenotypic and genotypic associations. METHODS: We extracted 5120 neural network–derived ECG features from an artificial intelligence–enabled ECG model trained for 6 simple diagnoses and applied unsupervised machine learning to identify 3 phenogroups. Using the identified phenogroups, we externally validated our findings in 5 diverse cohorts from the United States, Brazil, and the United Kingdom. Data were collected between 2000 and 2023. RESULTS: In total, 1 808 584 patients were included in this study. In the derivation cohort, the 3 phenogroups had significantly different mortality profiles. After adjusting for known covariates, phenogroup B had a 20% increase in long-term mortality compared with phenogroup A (hazard ratio, 1.20 [95% CI, 1.17–1.23]; P P P P P P SCN10A , SCN5A , and CAV1 have roles in cardiac conduction and arrhythmia. ARHGAP24 does not have a clear cardiac role and may be a novel target. CONCLUSIONS: Neural network–derived ECG features can be used to predict all-cause mortality and future cardiovascular diseases. We have identified biologically plausible and novel phenotypic and genotypic associations that describe mechanisms for the increased risk identified.


  • Open Access

    Midlife heart rate variability and cognitive decline: A large longitudinal cohort study

    by Vera K. Jandackova, Shaun Scholes, Annie Britton, Andrew Steptoe


  • Open Access

    Alcohol Consumption and Adiposity: A Longitudinal Analysis of 45,399 UK Biobank Participants

    by Elif Inan-Eroglu, Bo-Huei Huang, Mark Hamer, Annie Britton, Emmanuel Stamatakis

    The evidence on the association between alcohol consumption and adiposity is inconsistent and fragmented. We investigated the longitudinal association between alcohol consumption pattern and four different adiposity markers with repeated measures of adiposity and obesity incidence. We categorized current drinkers based on the sex-specific quartiles of their weekly alcohol consumption and the UK alcohol drinking guidelines. We used multivariable adjusted generalised linear models. With the exception of a direct association between alcohol volume and body fat percentage (BF%) in women (B = 0.42%; 95%CI: 0.04, 0.80% for women in the top quartile), we found no associations between alcohol consumption and adiposity markers for either sex. Red wine and champagne/white wine consumption were inversely associated with waist circumference (WC) for both sexes (B = −0.58 cm, 95%CI: −0.77, −0.38 cm and B= −0.49 cm, 95%CI: −0.68, −0.29 cm, respectively, for women; B = −0.28 cm, 95%CI: −0.47, −0.08 cm and B = −0.23 cm, 95%CI: −0.42, −0.04 cm, respectively, for men). Female and male spirit drinkers had higher WC than non-spirit drinkers. Alcohol consumption was associated with a lower risk of obesity incidence in women (OR:0.60, 95%CI:0.45, 0.80 for the 2nd quartile, OR:0.53, 95%CI: 0.40, 0.70 for the 3rd quartile and OR:0.61, 95%CI:0.46, 0.80 for the 4th quartile). We found limited evidence of longitudinal associations between alcohol intake and adiposity. The few statistically significant associations we observed are unlikely to be of clinical importance.


  • Open Access

    Workplace interventions for cardiovascular diseases: protocol of a systematic review and meta-analysis

    by Christian Moretti Anfossi, Christian Tobar Fredes, Felipe Pérez Rojas, Francisca Cisterna Cid, Christian Siques Urzúa, Jamie Ross, Jenny Head, Annie Britton

    Introduction: Cardiovascular diseases (CVDs) are the number one cause of death globally, impacting on public and private sectors. Current traditional interventions to prevent CVDs are mainly provided in healthcare centres and even when they are effective, they are not enough to reduce the rising prevalence; therefore, additional strategies are needed. Evidence suggests that health interventions in the workplace supply numerous benefits improving cardiovascular risk factor profiles in individuals. Hence, the aim of this systematic review and meta-analysis is to collate the evidence from randomised controlled trials, cluster randomised trials and quasi-experimental studies of workplace interventions to determine their effectiveness in terms of improving cardiovascular risk factors and preventing CVDs. Methods and analysis: EMBASE, PsycINFO, PubMed, the Cochrane Central Register of Controlled Trials, LILACS, Scopus, Web of Science, WHO International Clinical Trials Registry Platform, ClinicalTrials.gov and ProQuest Dissertations & Theses Global will be searched to include articles on workplace interventions in adults for CVDs events, cardiometabolic risk factors or behavioural risk factors. The study selection, data extraction, risk of bias and the assessment of the quality of the body of evidence will be conducted by two reviewers working in parallel and disagreements will be resolved by consensus or consultations with a third reviewer. Data synthesis will be done by meta-analysis using random-effects models when possible, otherwise the vote counting method will be applied. Statistical heterogeneity will be assessed by a χ 2 test and I 2 statistics. The quality of the body of evidence for each outcome will be assessed by applying the Grading of Recommendations, Assessment, Development and Evaluation approach. Ethics and dissemination: Ethical approval is not required for this systematic review protocol. The results of the systematic review will be published in a peer-reviewed journal and will be publicly available. PROSPERO registration number: CRD42021276161.


  • Open Access

    Trajectories of alcohol consumption in relation to all‐cause mortality in patients with cardiovascular disease: a 35‐year prospective cohort study

    by Chengyi Ding, Dara O'NEill, Annie Britton

    Background and Aims: Research into alcohol consumption and cardiovascular disease (CVD) patients' prognosis has largely ignored the longitudinal dynamics in drinking behaviour. This study measured the association between alcohol consumption trajectories and mortality risk in CVD patients.Design: Prospective cohort study.Setting: UK‐based Whitehall II Study.Participants: A total of 1306 participants with incident non‐fatal CVD (coronary heart disease/stroke) events.Measurements: Up to eight repeated measures of alcohol intake were available for each patient from the most recent assessment phase pre‐incident CVD and all subsequent phases post‐incident CVD, spanning up to three decades. Six trajectory groups of alcohol consumption were identified using group‐based trajectory modelling and related to the risk of all‐cause mortality, adjusting for demographics and changes in life‐style and health status.Findings: Three hundred and eighty deaths were recorded during a median follow‐up of 5 years after patients' last alcohol assessment. Compared with patients who consistently drank moderately (≤ 14 units/week), former drinkers had a greater risk of mortality (hazard ratio = 1.74, 95% confidence interval = 1.19–2.54) after adjustment for covariates. There was no significantly increased risk of mortality in long‐term abstainers, reduced moderate drinkers, stable or unstable heavy drinkers. Cross‐sectional analyses based only on drinking information at patients' last assessment found no significant differences in mortality risk for abstainers, former or heavy drinkers versus moderate drinkers.Conclusions: Cardiovascular disease patients who consistently drink ≤ 14 units/week appear to have a similar risk of mortality to those who are long‐term abstainers, which does not support a protective effect of moderate drinking on total mortality. Cardiovascular disease patients who stop drinking appear to have increased mortality risk compared with continuous moderate drinkers, but this may be linked to poor self‐rated health before cardiovascular disease onset.